Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Total Liabilities (2016 - 2021)

Historic Total Liabilities for ENDRA Life Sciences (NDRA) over the last 6 years, with Q3 2021 value amounting to $2.2 million.

  • ENDRA Life Sciences' Total Liabilities rose 651.16% to $2.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was $2.2 million, marking a year-over-year increase of 651.16%. This contributed to the annual value of $1.6 million for FY2020, which is 3394.37% down from last year.
  • According to the latest figures from Q3 2021, ENDRA Life Sciences' Total Liabilities is $2.2 million, which was up 651.16% from $2.3 million recorded in Q2 2021.
  • In the past 5 years, ENDRA Life Sciences' Total Liabilities registered a high of $2.4 million during Q4 2019, and its lowest value of $162302.0 during Q2 2017.
  • Moreover, its 5-year median value for Total Liabilities was $1.6 million (2020), whereas its average is $1.5 million.
  • Within the past 5 years, the most significant YoY rise in ENDRA Life Sciences' Total Liabilities was 58080.31% (2018), while the steepest drop was 5531.06% (2018).
  • Quarter analysis of 5 years shows ENDRA Life Sciences' Total Liabilities stood at $848214.0 in 2017, then rose by 14.9% to $974583.0 in 2018, then soared by 147.86% to $2.4 million in 2019, then plummeted by 33.94% to $1.6 million in 2020, then soared by 35.25% to $2.2 million in 2021.
  • Its Total Liabilities was $2.2 million in Q3 2021, compared to $2.3 million in Q2 2021 and $1.0 million in Q1 2021.